Article

Biopsy at low PSA levels may translate into better clinical outcomes

Chicago-A biopsy of men with PSA levels of 2.6 to 4.0 ng/mL may detectorgan-confined prostate cancer more often than a biopsy in men with a PSAlevel >4.0 ng/mL, according to a large study from Washington University,St. Louis, presented yesterday. This may result in better clinical outcomes,including a lower biochemical progression rate.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

© 2025 MJH Life Sciences

All rights reserved.